http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0244203-A3

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_28b082689e57fa5b81bb04274c120661
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_50f09ab19fbfeef3868178fcd3253847
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_671d008452921a0d439716af976cadae
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6512b5f73dc7c4b366e5a5e27ef60d28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3ff0257560acfe6f7bb28d63c5bd9fc7
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-51
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-08
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P19-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-51
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-495
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N1-21
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12P21-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-09
filingDate 2001-11-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a5c710a4fb40cc456ef7d65a0785d82a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a7b4a61dd550d206aaff53d8fb13ab1e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_815edf5f9c98afbbd762e4e04e54819a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d62378d8d182ae2a55b11a6cdcc9bc72
publicationDate 2003-04-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-0244203-A3
titleOfInvention Production of recombinant bmp-2
abstract In order to recombinantly produce a biologically active protein of the TGF β superfamily, a protein is expressed in prokaryotes. The amino terminus of this expressed protein consists of the prosequence of a protein of the TGF β superfamily or portions thereof, to which the mature domain of this protein or of another protein of the TGF β superfamily is joined, said protein having at least 35 % homology to mature BMP-2. The expression of the protein is carried out under conditions in which at least one portion of the protein is obtained in the form of inclusion bodies. The inclusion bodies are isolated and are solubilized under denaturing conditions. The denatured, monomeric and biologically inactive protein, which is solubilized from the inclusion bodies, is natured while folding and dimerizing to the soluble, biologically active conformation and, optionally, the mature protein is proteolytically released from its proform after naturation.
priorityDate 2000-11-29-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5013649-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9855137-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9700886-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0056879-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3641960
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226409109
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458396401

Total number of triples: 33.